Phase 3 ICARIA-MM trial of isatuximab #ASH19 #ASH @sanofi

Phase 3 ICARIA-MM trial of isatuximab #ASH19 #ASH @sanofi

ash

3 months
29 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Zsuzsanna Devecseri, MD of @SanofiGenzyme @sanofi discusses the pivotal Phase 3 ICARIA-MM trial of isatuximab, an investigational anti-CD38 monoclonal antibody, in relapsed/refractory multiple myeloma (RRMM) presented at the ASH.

Up Next Autoplay